Ironwood Pharmaceuticals Inc (IRWD) — Cash Flow Quality Index
Ironwood Pharmaceuticals Inc (IRWD) has a Cash Flow Quality Index of 0.13x as of March 2026. Operating cash flow of $5.12 Million is below net income of $40.77 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Ironwood Pharmaceuticals Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Ironwood Pharmaceuticals Inc Cash Flow Quality Index (2019–2025)
Historical Cash Flow Quality Index for Ironwood Pharmaceuticals Inc across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Ironwood Pharmaceuticals Inc (IRWD) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Ironwood Pharmaceuticals Inc (2019–2025)
Year-by-year earnings quality comparison for Ironwood Pharmaceuticals Inc. For live market cap and the full company financial profile, see Ironwood Pharmaceuticals Inc market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 5.29x | $127.04 Million | $24.02 Million | ▼ -95.5% |
| 2024 | 117.67x | $103.55 Million | $880.00K | ▲ +7424.7% |
| 2022 | 1.56x | $273.76 Million | $175.06 Million | ▲ +215.5% |
| 2021 | 0.50x | $261.89 Million | $528.45 Million | ▼ -68.8% |
| 2020 | 1.59x | $168.84 Million | $106.18 Million | ▲ +218.8% |
| 2019 | 0.50x | $10.72 Million | $21.50 Million | — |